This company has shut down. Combangio is no longer operating — its last tracked round was a Grant in 2023.
Explore the Startup GraveyardCombangio is a clinical-stage biotechnology company focused on developing regenerative biotherapeutics.
Combangio has raised $15.0M in total funding. The most recent round was Grant. The last funding was announced in April 2023.
Combangio's investors include California Institute for Regenerative Medicine.
Combangio is headquartered in California, United States.
Combangio is a clinical-stage biotechnology company focused on developing regenerative biotherapeutics.
Combangio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Combangio — Funding & Investors." VCBacked, April 28, 2023, https://www.vcbacked.co/company/combangio. Accessed August 14, 2026.
VCBacked. (2023). Combangio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/combangio
{{cite web |title=Combangio — Funding & Investors |url=https://www.vcbacked.co/company/combangio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated